D-Bal MAX Review 2025: Best Dianabol Steroid Alternative For Muscle Growth & Bodybuilding D-Bal Max Version 2 Pills For Sale

June 23, 2025 11:25 AM

D-Bal MAX is powerful supplement bodybuilders have used for years to help them get the most out of their workouts. It takes your body to the next level and makes you feel stronger, faster, and more confident about yourself.D-Bal MAX is made from all-natural ingredients, which means it's free of fillers or other harmful additives. It contains an amazing array of nutrients, including vitamins B6 and B12, zinc, iron, and magnesium essential for...

Read more

Curiosity Cube Debuts in Africa and Expands Global STEM Mission

June 23, 2025 11:00 AM

After captivating students across North America and Europe with access to hands-on science, the Curiosity Cube from the Life Science business of Merck KGaA, Darmstadt, Germany has launched its first-ever tour in Africa. To celebrate the inaugural tour, the Curiosity Cube held a kickoff event on June 10 at the University of South Africa (UNISA) in Johannesburg.During the launch event, volunteers from UNISA and the Life Science business of Merck...

Read more

International Demand Surges for U.S. Revenue Cycle Management Solutions Amid Rapid Private Insurance Expansion, Black Book Reports

June 23, 2025 10:30 AM

As healthcare systems worldwide increasingly blend public coverage with expanding private insurance models, updated research from Black Book Market Research reveals surging international demand for U.S.-based Revenue Cycle Management (RCM) technologies. Black Book's latest global market survey, distributed at the HFMA 2025 Annual National Institute (ANI) conference, identifies ten nations experiencing rapid growth in private healthcare insurance...

Read more

ASRT Launches Phase Two of the Be Seen Campaign

June 23, 2025 10:00 AM

The American Society of Radiologic Technologists has launched the second phase of its Be Seen public awareness campaign.Be Seen is a comprehensive communications campaign that raises the profile of medical imaging and radiation therapy professionals among the public, health care professions and elected officials.Bolstered by more than 50 million impressions secured in the first phase through television, advertising, social media, earned media,...

Read more

AbinoNutra Introduces Dual-Therapy Approach for Cellular Longevity: NR and FDA-GRAS L-Ergothioneine Combination

June 23, 2025 10:00 AM

Key Takeaways• Telomere Economy - Repeated oxidative hits erode telomeres; lowering ROS may slow that decline.• Dual-Axis Strategy - Pairing nicotinamide riboside (NR) with FDA-GRAS L-ergothioneine (EGT) may help deliver both NAD⁺ resupply and telomere shielding.• Dose Logic - Ten milligrams per day EGT saturates the OCTN-1 transporter and is clinically tolerated.• Early Signal - An AbinoPharm open-label pilot reported a 34 % median drop in...

Read more

Healthcare Providers Brace for Major RCM Changes as State Legislation Looms, Black Book Research Finds

June 23, 2025 9:00 AM

As healthcare providers across the United States confront an increasingly fragmented regulatory landscape, a newly updated report from Black Book Research reveals a sharp escalation in state-level legislative actions that are reshaping revenue cycle management (RCM) frameworks. The latest findings, based on extensive survey data and policy tracking through June 15, 2025, show that a growing number of healthcare organizations are re-evaluating...

Read more

Jaguar Health Provides Updates on Orphan Disease Intestinal Failure Development Program for Crofelemer

June 23, 2025 9:00 AM

Jaguar Health, Inc.(NASDAQ:JAGX) (Jaguar) today provided updates on the company's orphan disease intestinal failure program. Jaguar, through Jaguar family companies Napo Pharmaceuticals (Napo) and Napo Therapeutics, is currently supporting two independent proof-of-concept investigator-initiated trials (IITs), and conducting two placebo-controlled Phase 2 studies, of crofelemer, Jaguar's novel plant-based anti-secretory prescription drug, in...

Read more

Rezolut Recognized Among Georgia's Fastest-Growing Companies by ACG Atlanta

June 23, 2025 9:00 AM

Rezolut, a national medical imaging provider known for delivering innovative and patient-centered diagnostic care, has been named one of the 2025 Georgia Fast 40 by the Atlanta Chapter of the Association for Corporate Growth® (ACG). Ranking #17 among middle-market companies, Rezolut was honored at the Georgia Fast 40 Celebration held June 12 at Flourish Atlanta.The ACG Fast 40 recognizes Georgia-based upper middle-market companies that have...

Read more

Aytu BioPharma Expands and Extends Lending Agreement with Eclipse Following Agreement to Commercialize First-in-Class Antidepressant EXXUA(TM)

June 23, 2025 8:00 AM

Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, today announced it has successfully expanded and extended its lending agreement with Eclipse Business Capital LLC ("Eclipse"), providing added working capital flexibility as the Company prepares for the commercial launch of EXXUA™...

Read more

Avant Brands Strengthens Global Position with Strategic International Supply Agreements and 30+ New Product Rollout Across Canadian Provinces

June 23, 2025 7:30 AM

Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products, is pleased to announce several significant developments that underscore the Company's accelerating global growth strategy and strengthening market leadership across Canada.Strategic International Supply Agreements SignedAvant has entered into two multi-year international supply agreements serving...

Read more

Anosh Ahmed Extends Humanitarian Mission with New Global Relief Initiatives

June 23, 2025 5:50 AM

Dr. Anosh Ahmed, a well-known physician and entrepreneur, is expanding his humanitarian mission. He has launched new global relief initiatives to support communities in urgent need around the world. Anosh Ahmed leads the Anosh Inc Foundation in quick aid efforts. The foundation provides vital resources to people hit by natural disasters, poverty, and health crises. These new initiatives will strengthen relief efforts in areas facing serious...

Read more

3Aware Announces Formation of Scientific Advisory Board

June 23, 2025 5:00 AM

3Aware, a leading innovator in real-world evidence (RWE) solutions for the medical device industry, today announced the formation of its Scientific Advisory Board. The Board will advise on clinical, regulatory, and scientific strategy to support the company's work in RWE for medical devices.The Board's inaugural members are Dr. Bassil Akra, Dr. Philippe Auclair, and Dr. Trevor Carden. Dr. Akra will serve as Chair of the Scientific Advisory...

Read more

DEA Blocks MMJ FDA Cannabis Research While Tribal Marijuana Transit Networks Operate in N.C. Unchecked

June 23, 2025 5:00 AM

The U.S. Drug Enforcement Administration (DEA) continues to obstruct legally compliant cannabis research for debilitating conditions like Multiple Sclerosis (MS) and Huntington's Disease (HD)-even as marijuana distribution networks tied to tribal transit operations in North Carolina move quantities of cannabis across state lines with little to no DEA enforcement. MMJ BioPharma Cultivation, a Rhode Island-based biopharmaceutical company, has...

Read more

Ocean Optics Users Dive Deep Into Scientific Applications, Driving Record Engagement With Bioz Tools

June 23, 2025 4:00 AM

Bioz, Inc., a driving force in AI-powered literature search and product transparency, is excited to announce the success of its partnership with Ocean Optics, a global leader in optical sensing and spectroscopy solutions. With the integration of Bioz Pro Badges and a dedicated Bioz Content Hub, Ocean Optics is elevating its digital web experience for researchers by providing transparent, data-driven product validation and discovery tools...

Read more

BioNxt Launches Feasibility Study for Semaglutide Oral Thin Film as Alternative to Injection/Tablets

June 23, 2025 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC:BNXTF)(FSE:BXT), is pleased to announce the launch of a feasibility study for the development of an oral dissolvable film (ODF) formulation of Semaglutide, a GLP-1 receptor agonist currently marketed globally under the brand names Ozempic®, Rybelsus®, and Wegovy®.This initiative marks a significant step in evaluating BioNxt's proprietary thin film drug delivery platform as a...

Read more

Bausch Health Partners with YUN to Bring Pioneering Microbiome Skincare to Poland

June 23, 2025 1:00 AM

LAVAL, QC/ ACCESS Newswire / June 23, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, announced today it has entered a strategic partnership with YUN NV, an innovative leader in microbiome skincare solutions. This collaboration is set to transform the skincare landscape, starting with the launch of YUN's probiotic-based products for acne-prone skin to the Polish market later this year. YUN,...

Read more

Bloomberg's War on Harm Reduction Faces Consumer Backlash at Tobacco Conference

June 23, 2025 12:00 AM

On the eve of the World Conference on Tobacco Control (WCTC), a lightshow illuminated the conference centre in Dublin, sending a clear message: millions of consumers are being left out of the conversation on global tobacco and nicotine policy. The event, organised by the World Vapers' Alliance, launched the "Voices Unheard - Consumers Matter!" campaign to highlight the ongoing marginalisation of those most affected by tobacco control...

Read more

Dr. Anosh Ahmed's Philanthropic Vision: Empowering Underserved Chicago Communities

June 22, 2025 10:50 PM

Dr. Anosh Ahmed, a respected Chicago-based entrepreneur, physician, and philanthropist, is deepening his commitment to underserved communities across Chicago through a series of sustained charitable programs. As the founder of the Anosh Ahmed Foundation, he leads efforts that combine compassion with action, creating meaningful change across neighborhoods like Austin, Englewood, and Little Village.Dr. Anosh Ahmed ImageOver the past year, Dr....

Read more

DEA Judge Mulrooney’s MMJ Marijuana Ruling May Be DEA’s Last Stand Before the Constitution Strikes Back

June 22, 2025 5:00 AM

In a move that now appears both unconstitutional and strategically reckless, the Drug Enforcement Administration's (DEA) Chief Administrative Law Judge John J. Mulrooney II has ruled against MMJ BioPharma Cultivation - not by adjudicating evidence, but by canceling the hearing altogether, shutting the courtroom door before any facts could be presented. This denial of due process is not just procedural misconduct. It stands in direct violation...

Read more

Inka Health Co-Founders Publish New Study Advancing Real-World Applicability of Lung Cancer Clinical Trial Outcomes

June 20, 2025 6:00 PM

Onco-Innovations Limited(CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that the Co-Founders of its wholly-owned subsidiary, Inka Health Corp. ("Inka Health"), have authored a significant new study titled Global Transportability of Clinical Trial Outcomes to Real-World Lung Cancer Populations: A Case Study using Lung-MAP S1400I1 (the "Study"), published in medRxiv in June 2025. The Study...

Read more